They found that tumor cells having high level of SLC7A11 expression were more sensitive to the level of glucose and glutamine restrictions than these cells with low level of SLC7A11 expression, which may due to the high nutrient dependence of tumor cells. The gene discussed is SLC7A11; the disease is neoplasm.